Cidel Asset Management Inc Astrazeneca PLC Transaction History
Cidel Asset Management Inc
- $1.17 Billion
- Q1 2024
A detailed history of Cidel Asset Management Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Cidel Asset Management Inc holds 651,121 shares of AZN stock, worth $50 Million. This represents 3.78% of its overall portfolio holdings.
Number of Shares
651,121
Previous 559,259
16.43%
Holding current value
$50 Million
Previous $37.7 Million
17.12%
% of portfolio
3.78%
Previous 1.86%
Shares
26 transactions
Others Institutions Holding AZN
# of Institutions
1,248Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.71 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.77 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.3 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.65 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.33 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $238B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...